CHRISTENSEN DAVID EUGENE (President and CEO) received a stock award from REGENERATIVE MEDICAL TECHNOLOGY GROUP INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/19/2021ACC: 0001213900-21-043904
→
DirectorOfficer10% Owner· President and CEO
Since Nov 2019
+448.00
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
448.00 acquired
Non-Derivative Transactions1
Series DD Preferred Stock
Direct
Shares
+448.00
Price / share
—
Trade value
—
% of position
New position
8/18/2021
0.00→448.00
Total
Net shares
+448.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series DD Preferred Stock Direct | 8/18/2021 | A · Award | +448.00 | — | — | New position | 0.00 | 448.00 |
| Total | +448.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported